Atlas Trials

CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy

Clinical trial NCT03851237 · COMPLETED

Trial details

NCT number
NCT03851237
Sponsor
Washington University School of Medicine
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Pancreatic Ductal Adenocarcinoma
Start date
2019-01-02
Primary completion
2025-12-19
Enrollment
69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.